SC
Shreepal Champalal Jain
About Shreepal Champalal Jain
Data last updated:
Shreepal Champalal Jain is a Director at Ripharma Laboratories Limited (since 2015), Director at Skyline Construtech Private Limited (since 2012) and Director at Rishabh Indotex Limited (since 2004). The companies operate in Pharma, Real Estate and Construction and Home & Lifestyle. The 3 current companies with reported revenue have a combined latest revenue of ₹68.32 Cr; the largest is Ripharma Laboratories Limited at ₹68.14 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ripharma Laboratories Limited U24100MH2015PLC262970 | Director | 25 Mar 2015 | 2015 | ₹68.14 Cr (FY 2025) | Active |
 Skyline Construtech Private Limited U45400MH2012PTC236665 | Director | 10 Oct 2012 | 2012 | ₹18.8 Lakh (FY 2025) | Active |
| Rishabh Indotex Limited U17120MH2004PLC145794 | Director | 20 Apr 2004 | 2004 | ₹1,765 (FY 2024) | Active |
Board colleagues of Shreepal Champalal Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Shantilal Jain | 06864989 | Ripharma Laboratories Limited | Director |
| Milan Champalal Jain | 06388938 | Ripharma Laboratories Limited , Skyline Construtech Private Limited and 1 more | Director |
| Rishabh Shreepal Jain | 06976344 | Ripharma Laboratories Limited | Director |
| Shantilal Rajmal Jain | 00457742 | Ripharma Laboratories Limited , Skyline Construtech Private Limited | Director |
| Shrenik Champalal Jain | 00457755 | Ripharma Laboratories Limited , Skyline Construtech Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shreepal Champalal Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shreepal Champalal Jain
Shreepal Champalal Jain currently holds 3 directorships: Ripharma Laboratories Limited (Director, since 25 Mar 2015, revenue ₹68.14 Cr (FY 2025)); Skyline Construtech Private Limited (Director, since 10 Oct 2012, revenue ₹18.8 Lakh (FY 2025)); Rishabh Indotex Limited (Director, since 20 Apr 2004, revenue ₹1,765 (FY 2024)).
Shreepal Champalal Jain was first appointed on 20 Apr 2004 as Director at Rishabh Indotex Limited. The most recent appointment on record is 25 Mar 2015 at Ripharma Laboratories Limited.
The 3 current companies of Shreepal Champalal Jain that report revenue have a combined latest revenue of ₹68.32 Cr: Ripharma Laboratories Limited ₹68.14 Cr (FY 2025); Skyline Construtech Private Limited ₹18.8 Lakh (FY 2025); Rishabh Indotex Limited ₹1,765 (FY 2024).
The current boards of Shreepal Champalal Jain's companies include Amit Shantilal Jain (Ripharma Laboratories Limited), Milan Champalal Jain (Ripharma Laboratories Limited), Rishabh Shreepal Jain (Ripharma Laboratories Limited), Shantilal Rajmal Jain (Ripharma Laboratories Limited), Shrenik Champalal Jain (Ripharma Laboratories Limited).